Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis.
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.
Francesco
F
Caso
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.
Ugo
U
Fiocco
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.
Luisa
L
Costa
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.
Paolo
P
Sfriso
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.
Leonardo
L
Punzi
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy. Electronic address: adoria@unipd.it.
Andrea
A
Doria
D000293:Adolescent; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D006801:Humans; D006942:Hypergammaglobulinemia / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D000069283:Rituximab; D015423:Scleritis / Q000188:drug therapy* / Q000276:immunology
D058846:Antibodies, Monoclonal, Murine-Derived; D007074:Immunoglobulin G; D007155:Immunologic Factors; D000069283:Rituximab
Anti-CD20 monoclonal antibody (rituximab); IgG4-RD; Scleritis